These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 6217742)
1. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742 [TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
3. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas. Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716 [TBL] [Abstract][Full Text] [Related]
6. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207 [TBL] [Abstract][Full Text] [Related]
7. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T; Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma. Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223 [TBL] [Abstract][Full Text] [Related]
12. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland]. Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for metastatic carcinoma of the ampulla of Vater--report of three cases. Bukowski RM; Hermann RE; Theodors A J Surg Oncol; 1984 Apr; 25(4):284-6. PubMed ID: 6232429 [TBL] [Abstract][Full Text] [Related]
15. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study. Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
17. [Low-dose intermittent intra-arterial infusion chemotherapy]. Arai Y; Kido C Gan To Kagaku Ryoho; 1985 Oct; 12(10):1922-9. PubMed ID: 2996438 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer. Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982 [No Abstract] [Full Text] [Related]
19. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Gibson MK; Holcroft CA; Kvols LK; Haller D Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215 [TBL] [Abstract][Full Text] [Related]
20. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer. Papachristou E; Link KH; Schoenberg MH Anticancer Res; 2003; 23(2A):831-4. PubMed ID: 12820308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]